

ONG DIKO is a Nigerien African non-governmental development and humanitarian organisation with a universal vocation and based on ethical values that guide its work. It was created on October 22, 2006 by young progressive students and rights activists under the name “Association pour le Secours aux Populations Vulnérables (ASPV)”. In 2009, this association evolved into an NGO by ministerial decree with the name DIKO, which means “SUPPORT” in the Djerma language.
Its mission is to support vulnerable populations, particularly women, children, and people with special needs, by promoting social justice, combating inequality, and respecting human rights. They operate using an approach based primarily on human rights.
ONG DIKO works to prevent water-related diseases, hygiene, and sanitation, including hepatitis A and E caused by the consumption of water or food contaminated by faecal matter. Their interventions focus on access to safe drinking water and adequate sanitation through targeted awareness-raising, advocacy, capacity building, the provision of hygiene kits and infrastructure, etc., for the benefit of vulnerable populations. Their commitment to the fight against hepatitis goes far beyond their daily advocacy efforts, raising awareness among authorities, training healthcare personnel, and increasing access to health centres. With 10 years of experience in the field, they have developed in-depth expertise and a nuanced understanding of the multiple facets of this public health issue. Their holistic approach translates into significant involvement in [mention other specific areas of expertise here, for example:
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close